Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed  - 05/03 04:24:22 pm
20220 ILa   +0.60%
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale ..
04/29 TEVA PHARMACEUT : Announces FDA Approval of ProAir RespiClick® (albu..
04/25 TEVA PHARMACEUT : Jennifer Morrison Reveals How Her Journey with Mig..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/01/2013 | 01:27pm CEST
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on TEVA PHARMACEUTICAL INDUST
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale Activist Inv..
04/29 TEVA PHARMACEUTICAL : Announces FDA Approval of ProAir RespiClick® (albuterol su..
04/28 TEVA PHARMACEUTICAL : to Report First Quarter 2016 Financial Results on May 9, 2..
04/28 TEVA PHARMACEUTICAL : Presents New Data for SD-809 in Huntington Disease at 68th..
04/25 TEVA PHARMACEUTICAL : Jennifer Morrison Reveals How Her Journey with Migraine is..
04/23 TEVA PHARMACEUTICAL : TEVA) Stake Cut by Westfield Capital Management Co. LP
04/21 TEVA PHARMACEUTICAL : to Present Data Highlighting Company's Pipeline in Neurolo..
04/19 TEVA PHARMACEUTICAL : Presents New Data for SD-809 in Huntington Disease at 68th..
04/18 TEVA PHARMACEUTICAL : to Report First Quarter 2016 Financial Results on May 9, 2..
04/18 TEVA PHARMACEUTICAL : Presents New Data for SD-809 in Huntington Disease at 68th..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials